litlas
ログインアカウント作成

Hui Feng

1997–2026 年に発表

579
論文数
36,265
被引用数
96
h 指数
388
i10 指数

被引用数

Hui Feng の年別被引用数1996 年: 被引用 1 件1998 年: 被引用 2 件1999 年: 被引用 1 件2000 年: 被引用 5 件2001 年: 被引用 6 件2002 年: 被引用 7 件2003 年: 被引用 13 件2004 年: 被引用 28 件2005 年: 被引用 18 件2006 年: 被引用 35 件2007 年: 被引用 25 件2008 年: 被引用 30 件2009 年: 被引用 28 件2010 年: 被引用 47 件2011 年: 被引用 69 件2012 年: 被引用 67 件2013 年: 被引用 80 件2014 年: 被引用 134 件2015 年: 被引用 184 件2016 年: 被引用 250 件2017 年: 被引用 299 件2018 年: 被引用 340 件2019 年: 被引用 754 件2020 年: 被引用 1,225 件2021 年: 被引用 1,571 件2022 年: 被引用 1,434 件2023 年: 被引用 1,191 件2024 年: 被引用 2,007 件2025 年: 被引用 1,103 件2026 年: 被引用 116 件1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 5,144 件、この内訳の 35.3%アメリカ合衆国: 引用元論文 2,314 件、この内訳の 15.9%イギリス: 引用元論文 540 件、この内訳の 3.7%インド: 引用元論文 472 件、この内訳の 3.2%ドイツ: 引用元論文 441 件、この内訳の 3%イタリア: 引用元論文 359 件、この内訳の 2.5%オーストラリア: 引用元論文 353 件、この内訳の 2.4%カナダ: 引用元論文 342 件、この内訳の 2.3%日本: 引用元論文 302 件、この内訳の 2.1%フランス: 引用元論文 301 件、この内訳の 2.1%韓国: 引用元論文 301 件、この内訳の 2.1%スペイン: 引用元論文 230 件、この内訳の 1.6%
0%35.3%その他 23.8%

機関

分野

  • Medicine34.5%
  • Biochemistry, Genetics and Molecular Biology21.7%
  • Computer Science10.3%
  • Engineering8.9%
  • Materials Science8.1%
  • Agricultural and Biological Sciences4%
  • その他12.5%

トピック

  • SARS-CoV-2 and COVID-19 Research2.6%
  • Cancer Immunotherapy and Biomarkers2%
  • Advanced biosensing and bioanalysis techniques2%
  • Carbon and Quantum Dots Applications1.7%
  • Monoclonal and Polyclonal Antibodies Research1.3%
  • COVID-19 Clinical Research Studies1.2%
  • その他89.2%

共著者

全論文

検索で開く
  1. MemSeg: A semi-supervised method for image surface defect detection using differences and commonalities

    著者: Minghui Yang, Peng Wu, Hui Feng - Engineering Applications of Artificial Intelligence, Eng. Appl. Artif. Intell. 2023 被引用: 227

  2. Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

    著者: Zixian Wang, Chengxu Cui, Jun Yao, Yanqiao Zhang, Mengxia Li, Ji‐Feng Feng, Shujun Yang, Yun Fan, Jianhua Shi, Xizhi Zhang, Lin Shen, Yongqian Shu, Cailian Wang, Tianyang Dai, Teng Mao, Long Chen, Zengqing Guo, Bo Liu, Hongming Pan, Shundong Cang, Yi Jiang, Junye Wang, Min Ye, Zhendong Chen, Da Jiang, Qin Lin, Wei Ren, Junsheng Wang, Lin Wu, Yong Xu, Zhanhui Miao, Meili Sun, Conghua Xie, Ying Liu, Qifeng Wang, Lina Zhao, Qi Li, Canhong Huang, Ke Jiang, Kunyu Yang, Daojun Li, Yunpeng Liu, Zhitu Zhu, Rixin Chen, Liqun Jia, Wei Li, Wangjun Liao, Hongxu Liu, Daiyuan Ma, Jie Ma, Yanru Qin, Zhihong Shi, Qichun Wei, Ke Xiao, Yan Zhang, Ying Zhang, Xin Chen, Guanghai Dai, Jianxing He, Junhe Li, Guanghui Li, Yong Liu, Zhihua Liu, Xianglin Yuan, Junping Zhang, Zhichao Fu, Yifu He, Fang Ju, Zheng Liu, Peng Tang, Tiejun Wang, Weibo Wang, Jing Zhang, Xianming Luo, Xiongwen Tang, Rena May, Hui Feng, Sheng Yao, Patricia Keegan, Rui‐Hua Xu, Feng Wang - Cancer Cell 2022 被引用: 565

  3. Crop Phenomics and High-Throughput Phenotyping: Past Decades, Current Challenges, and Future Perspectives

    著者: Wanneng Yang, Hui Feng, Xuehai Zhang, Jian Zhang, John H. Doonan, William D. Batchelor, Lizhong Xiong, Jianbing Yan - Molecular Plant 2020 被引用: 914

  4. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

    著者: Rui Shi, Chao Shan, Xiaomin Duan, Zhihai Chen, Peipei Liu, Jin‐Wen Song, Tao Song, Xiaoshan Bi, Chao Han, Lianao Wu, Ge Gao, Ge Gao, Xue Hu, Yanan Zhang, Zhou Tong, Weijin Huang, William Jun Liu, Guizhen Wu, Bo Zhang, Lan Wang, Jianxun Qi, Hui Feng, Qihui Wang, Qihui Wang, George F. Gao, George Fu Gao, Zhiming Yuan, Jinghua Yan - Nature 2020 被引用: 1,499

  5. Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

    著者: Hai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, Chaosu Hu, Kunyu Yang, Jiyu Wen, Jingao Li, Ying-Rui Shi, Feng Jin, Ruilian Xu, Jianji Pan, Shenhong Qu, Ping Li, Chunhong Hu, Yi‐Chun Liu, Yi Jiang, Xia He, Hung-Ming Wang, Wan‐Teck Lim, Wangjun Liao, Xiaohui He, Xiaozhong Chen, Zhigang Liu, Xianglin Yuan, Qi Li, Xiaoyan Lin, Shanghua Jing, Yanju Chen, Lu Yin, Ching-Yun Hsieh, Muh‐Hwa Yang, Chia-Jui Yen, Jens Samol, Hui Feng, Sheng Yao, Patricia Keegan, Rui‐Hua Xu - Nature Medicine 2021 被引用: 403

  6. Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

    著者: Feng‐Hua Wang, Xiaoli Wei, Jifeng Feng, Qi Li, Nong Xu, Xichun Hu, Wangjun Liao, Yi Jiang, Xiaoyan Lin, Qingyuan Zhang, Xianglin Yuan, Haixin Huang, Ye Chen, Guanghai Dai, Jianhua Shi, Lin Shen, Shujun Yang, Yongqian Shu, Yunpeng Liu, Weifeng Wang, Hai Wu, Hui Feng, Sheng Yao, Rui‐Hua Xu - Journal of Clinical Oncology 2021 被引用: 351

  7. The emerging role and targetability of the TCA cycle in cancer metabolism

    著者: Nicole Anderson, Patrick Mucka, Joseph G. Kern, Hui Feng - Protein & Cell 2017 被引用: 564

  8. Expression, regulation, and function of exosome‐derived miRNAs in cancer progression and therapy

    著者: Bowen Li, Yu Cao, Mingjun Sun, Hui Feng - The FASEB Journal 2021 被引用: 262

  9. A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

    著者: John Y. Li, Samuel R. Perry, Vanessa Muniz‐Medina, Xinzhong Wang, Leslie Wetzel, Marlon C. Rebelatto, Mary Jane Hinrichs, Binyam Bezabeh, Ryan Fleming, Nazzareno Dimasi, Hui Feng, Dorin Toader, Andy Q. Yuan, Lan Xu, Jia Lin, Changshou Gao, Herren Wu, Rakesh Dixit, Jane Osbourn, Steven Coats - Cancer Cell 2016 被引用: 390

  10. Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

    著者: Zhijie Wang, Lin Wu, Baolan Li, Ying Cheng, Xiaoling Li, Xicheng Wang, Liang Han, Xiaohong Wu, Yun Fan, Yan Yu, Dongqing Lv, Jianhua Shi, Jianjin Huang, Shaozhang Zhou, Baohui Han, Guogui Sun, Qisen Guo, Youxin Ji, Xiaoli Zhu, Sheng Hu, Wei Zhang, Qiming Wang, Yuming Jia, Ziping Wang, Yong Song, Jingxun Wu, Meiqi Shi, Xingya Li, Zhigang Han, Yunpeng Liu, Zhuang Yu, Anwen Liu, Xiuwen Wang, Caicun Zhou, Diansheng Zhong, Liyun Miao, Zhihong Zhang, Hui Zhao, Jiaqi Yang, Dong Wang, Yingyi Wang, Qiang Li, Xiaodong Zhang, Mei Ji, Zhenzhou Yang, Jiuwei Cui, Beili Gao, Buhai Wang, Hu Liu, Lei Nie, Mei He, Jin Shi, Wei Gu, Yongqian Shu, Tong Zhou, Jian Feng, Xinmei Yang, Cheng Huang, Bo Zhu, Yu Yao, Xiongwen Tang, Jianjun Yu, Ellen Maher, Hui Feng, Sheng Yao, Patricia Keegan, Jie Wang - Journal of Clinical Oncology 2022 被引用: 172

  11. Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432

    著者: F. Wang, Xiaoli Wei, Fenggong Wang, Nong Xu, Lin Shen, Guanghai Dai, Xianglin Yuan, Y. Chen, S. Yang, Jiawei Shi, Xiang Hu, Xiandong Lin, Qilong Zhang, J. Feng, Yi Ba, Yanshi Liu, W. Li, Yongqian Shu, Yi Jiang, Quan Li, J.W. Wang, H. T. Wu, Hui Feng, Sheng Yao, Rui‐Hua Xu - Annals of Oncology 2019 被引用: 476

  12. Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma

    著者: Hai‐Qiang Mai, Qiuyan Chen, Dongping Chen, Chaosu Hu, Kunyu Yang, Jiyu Wen, Jingao Li, Yingrui Shi, Feng Jin, Ruilian Xu, Jianji Pan, Shenhong Qu, Ping Li, Chunhong Hu, Yi‐Chun Liu, Yi Jiang, Xia He, Hung‐Ming Wang, Wan‐Teck Lim, Wangjun Liao, Xiaohui He, Xiaozhong Chen, Siyang Wang, Xianglin Yuan, Qi Li, Xiaoyan Lin, Shanghua Jing, Yanju Chen, Lu Yin, Ching-Yun Hsieh, Muh‐Hwa Yang, Chia‐Jui Yen, Jens Samol, Xianming Luo, Xiaojun Wang, Xiongwen Tang, Hui Feng, Sheng Yao, Patricia Keegan, Rui‐Hua Xu - JAMA 2023 被引用: 233

  13. Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses

    著者: Hui Feng, Yi-Bing Zhang, Jian‐Fang Gui, Stanley M. Lemon, Daisuke Yamane - PLoS Pathogens 2021 被引用: 298

  14. Toward Packet Routing With Fully Distributed Multiagent Deep Reinforcement Learning

    著者: Xinyu You, Xuanjie Li, Yuedong Xu, Hui Feng, Jin Zhao, Huaicheng Yan - IEEE Transactions on Systems Man and Cybernetics Systems, IEEE Trans. Syst. Man Cybern. Syst. 2020 被引用: 99

  15. A Risk Prediction Model Based on Machine Learning for Cognitive Impairment Among Chinese Community-Dwelling Elderly People With Normal Cognition: Development and Validation Study

    著者: Mingyue Hu, Xinhui Shu, Gang Yu, Xinyin Wu, Maritta Välimäki, Hui Feng - Journal of Medical Internet Research 2021 被引用: 132

  16. Estimation of the soil arsenic concentration using a geographically weighted XGBoost model based on hyperspectral data

    著者: Miao Ye, Lin Zhu, Xiaojuan Li, Yinghai Ke, Yong Huang, Beibei Chen, Huilin Yu, Huan Li, Hui Feng - The Science of The Total Environment 2022 被引用: 136

  17. Comparative effectiveness of non-pharmacological interventions for frailty: a systematic review and network meta-analysis

    著者: Xuemei Sun, Wenqi Liu, Yinyan Gao, Lang Qin, Hui Feng, Hongzhuan Tan, Qiong Chen, Linlin Peng, Xinyin Wu - Age and Ageing 2023 被引用: 123

  18. Generation of multicomponent atomic Schrödinger cat states of up to 20 qubits

    著者: Chao Song, Kai Xu, Hekang Li, Yu-Ran Zhang, Xu Zhang, Wuxin Liu, Qiujiang Guo, Zhen Wang, Wenhui Ren, Jie Hao, Hui Feng, Heng Fan, Dongning Zheng, Da‐Wei Wang, H. Wang, Shi-Yao Zhu - Science 2019 被引用: 367

  19. Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism

    著者: Alex J. Bott, Jianliang Shen, Claudia Tonelli, Le Zhan, Nithya Sivaram, Ya-Ping Jiang, Xufen Yu, Vrushank Bhatt, Eric Chiles, H. Zhong, Sara Maimouni, Weiwei Dai, Stephani Velasquez, Ji-An Pan, Nathiya Muthalagu, Jennifer P. Morton, Tracy G. Anthony, Hui Feng, Wouter H. Lamers, Daniel J. Murphy, Jessie Yanxiang Guo, Jian Jin, Howard C. Crawford, Lanjing Zhang, Eileen White, Richard Z. Lin, Xiaoyang Su, David A. Tuveson, Wei‐Xing Zong - Cell Reports 2019 被引用: 195

  20. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7‐NLRP3 interaction

    著者: Qiang Li, Hui Feng, Hongbo Wang, Yinghao Wang, Wenqing Mou, Guang Xu, Ping Zhang, Ruisheng Li, Wei Shi, Zhilei Wang, Zhie Fang, Lutong Ren, Yan Wang, Li Lin, Xiaorong Hou, Wenzhang Dai, Zhiyong Li, Ziying Wei, Tingting Liu, Jiabo Wang, Yuming Guo, Pengyan Li, Xu Zhao, Xiaoyan Zhan, Xiaohe Xiao, Zhaofang Bai - EMBO Reports 2021 被引用: 108

  21. Combining high-throughput phenotyping and genome-wide association studies to reveal natural genetic variation in rice

    著者: Wanneng Yang, Zilong Guo, Chenglong Huang, Lingfeng Duan, Guoxing Chen, Ni Jiang, Wei Fang, Hui Feng, Weibo Xie, Xingming Lian, Gongwei Wang, Qingming Luo, Qifa Zhang, Qian Liu, Lizhong Xiong - Nature Communications 2014 被引用: 632

  22. Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial

    著者: Bixia Tang, Zhihong Chi, Yingbo Chen, Xiufeng Liu, Di Wu, Jing Chen, Xin Song, Weifeng Wang, Lihou Dong, Haifeng Song, Hai Wu, Hui Feng, Sheng Yao, Shuikui Qin, Xiaoshi Zhang, Jun Guo - Clinical Cancer Research 2020 被引用: 167

  23. Plant-Derived Exosome-Like Nanoparticles: Emerging Nanosystems for Enhanced Tissue Engineering

    著者: Hui Feng, Yue Yang, Yan Zhang, Jingqi Liang, Liang Liu, Qiong Wang, Qian Feng, Hongmou Zhao - International Journal of Nanomedicine 2024 被引用: 56

  24. Effectiveness of Exergaming in Improving Cognitive and Physical Function in People With Mild Cognitive Impairment or Dementia: Systematic Review

    著者: Yinan Zhao, Hui Feng, Xinyin Wu, Yan Du, Xiufen Yang, Mingyue Hu, Hongting Ning, Lulu Liao, Huijing Chen, Yishan Zhao - JMIR Serious Games 2020 被引用: 135